Teofilina e apnéia neonatal: alteraçös da oximetria e ritmo cardíaco

Reimäo, Rubens; Lemmi, Helio; Hamlett III, James; Sander, Craig; Zwagg, Roger Vander.
J. pediatr. (Rio J.) ; 58(3): 82-4, mar. 1985. tab
Artículo en Portugués | LILACS | ID: lil-3505

Documentos relacionados

  1. Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
  2. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
  3. Therapeutic drug monitoring of caffeine and its primary metabolites in plasma using LC-ESI-MS/MS for apnea of prematurity treatment: Evaluation of ultrapure water as a surrogate matrix.
  4. Caffeine versus theophylline for apnea in preterm infants.
  5. Letter: Questions on theophylline.
  6. Prevention of apnea and bradycardia in low-birthweight infants.
  7. Effect of serum caffeine level on pneumocardiogram of premature infants treated for apnea with theophylline.
  8. Use of caffeine in infants unresponsive to theophylline in apnea of prematurity.
  9. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
  10. CO(2) inhalation as a treatment for apnea of prematurity: a randomized double-blind controlled trial.